Chronic Hand Eczema clinical trials

Explore recruiting chronic hand eczema clinical trials.

Recruiting chronic hand eczema studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Hand Eczema trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety deucravacitinib in patients with chronic hand eczema

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Treatment of Chronic Hand Eczema with Oral Roflumilast (HERO) – a randomized controlled trial

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Double-Blind, Randomized, 16-Week, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Open-Label Extension Period in Adults With Chronic Hand Eczema

Germany, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Abrocitinib in Subjects with Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Chronic Hand Eczema trials by city

Chronic Hand Eczema in Toronto Chronic Hand Eczema in Vancouver Chronic Hand Eczema in Montreal Chronic Hand Eczema in Calgary Chronic Hand Eczema in Edmonton Chronic Hand Eczema in Ottawa Chronic Hand Eczema in Winnipeg Chronic Hand Eczema in Quebec City Chronic Hand Eczema in Hamilton Chronic Hand Eczema in Kitchener Chronic Hand Eczema in London Chronic Hand Eczema in Halifax Chronic Hand Eczema in New York Chronic Hand Eczema in Los Angeles Chronic Hand Eczema in Chicago Chronic Hand Eczema in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease